Date of response: 24 July 2025

Outcome: Information disclosed

Category: Joint Commissioning and Planned Care

Request

Tirzepatide (Mounjaro) for weight loss/obesity

ICB Response

NN ICB 25 1229 Response Letter

pdf (122K)

Close
Search